Drug Profile
EP 1090
Alternative Names: EP-1090; EP-HIV-1090; HIV DNA vaccine - VaxOnco; Pharmexa-Epimmune HIV-1 CTL epitope-based DNA vaccineLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Pharmexa-Epimmune
- Developer VaxOnco
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV-1 infections